Number of Clinical Trials 2024
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #149
Sri Lanka
- #148
South Sudan
- #147
Senegal
- #146
Réunion
- #145
Panama
- #144
Northern Mariana Islands
- #143
New Caledonia
- #142
Namibia
- #141
Monaco
- #140
Martinique
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Madagascar
In 2024, Madagascar ranks #136 globally with a total of 1 clinical trial. This figure is significantly lower than many of its regional neighbors, highlighting a lack of research activity in comparison to countries with more robust healthcare infrastructure and investment. Contributing factors include Madagascar's limited access to funding for medical research and a smaller population, which can restrict the scale and scope of clinical studies.
Taiwan
Taiwan ranks #15 globally with a total of 235 clinical trials in 2024. This figure positions Taiwan significantly above the global average, reflecting its advanced healthcare infrastructure and robust regulatory environment. The country's emphasis on biotechnology and pharmaceutical research, combined with a well-educated workforce, drives its strong performance in clinical trials.
Czech Republic
The Czech Republic ranks #39 globally with a total of 50 clinical trials in 2024. This figure positions the country above many regional peers, reflecting its robust healthcare infrastructure and research capabilities. The Czech Republic benefits from a well-educated workforce and a strategic location in Central Europe, making it an attractive destination for pharmaceutical companies and research organizations. Additionally, supportive government policies aimed at promoting innovation in the biotech sector further enhance its clinical trial landscape.
Iraq
In 2024, Iraq ranks #44 globally with a total of 32 clinical trials. This number is notably lower than the global average, reflecting challenges in research infrastructure compared to higher-ranked countries like the United States, which leads with thousands of trials. Iraq's clinical trial landscape is influenced by ongoing efforts to improve healthcare systems and regulatory frameworks, alongside a growing emphasis on medical research and partnerships with international organizations.
Argentina
In 2024, Argentina ranks #50 globally with a total of 23 clinical trials. This places it below the regional average for South America, where countries like Brazil lead with significantly higher numbers. The country's robust pharmaceutical industry and increasing investment in healthcare research contribute to its clinical trial activity, although regulatory challenges and economic instability can hinder further growth.
Slovakia
In 2024, Slovakia ranks #78 globally with a total of 8 clinical trials. This number is notably lower than the global average, reflecting a more limited research environment compared to leading countries in clinical research. Factors such as a smaller population and less investment in healthcare innovation contribute to this statistic, alongside a regulatory landscape that may not be as conducive to clinical trial activities as in neighboring nations.
Canada
In 2024, Canada ranks #8 globally with a total of 527 clinical trials. This figure places Canada above the global average, highlighting its significant role in the clinical research landscape. The country's robust healthcare system, strong regulatory framework, and a diverse population contribute to its attractiveness for clinical research initiatives. Additionally, government support for innovation and research funding enhances Canada's position as a leader in this field.
Austria
In 2024, Austria ranks #28 globally with a total of 86 clinical trials. This number reflects a robust research environment, especially when compared to regional neighbors like Hungary, which has fewer trials. Austria benefits from a strong healthcare system, significant investment in medical research, and a strategic location within Europe, facilitating collaboration and access to diverse patient populations.
Costa Rica
Costa Rica ranks #95 globally with a total of 3 clinical trials in 2024. This figure is notably lower than the regional average, indicating a need for growth in clinical research capacity compared to its neighbors. The limited number of clinical trials can be attributed to a smaller healthcare research infrastructure and a focus on primary healthcare rather than specialized clinical research initiatives.
Angola
In 2024, Angola ranks #120 globally with a total of 1 clinical trial. This figure is significantly lower than many neighboring countries, reflecting a regional average that often includes multiple trials per nation. The limited number of clinical trials in Angola can be attributed to challenges such as insufficient healthcare infrastructure, a lack of investment in research, and regulatory hurdles that hinder the development of clinical research initiatives.
Analysis & Context
In 2024, the United States leads the world with the highest Number of Clinical Trials, totaling 6222, while the global range spans from 1 to 6222. The median number of clinical trials conducted across countries is 8, providing a crucial context for understanding global disparities in medical research.
Global Leaders in Clinical Trials: The Role of Infrastructure and Investment
The dominance of the United States in clinical trials is closely tied to its robust infrastructure and significant investment in medical research. With 6222 trials, the U.S. not only leads in quantity but also in the diversity of research areas, supported by a combination of public and private funding. Similarly, countries like Turkey and China, with 2075 and 1649 trials respectively, have shown substantial growth, driven by strategic investments in healthcare and research facilities. China's emphasis on biotechnology and Turkey's strategic position as a bridge between continents likely contribute to their high rankings.
In France and Spain, which have 896 and 566 trials respectively, the presence of world-renowned universities and research institutions plays a critical role. These countries benefit from well-established healthcare systems and collaborations between academia and industry, fostering environments conducive to clinical research.
Challenges and Opportunities in Emerging Markets
While top-tier countries dominate the landscape, emerging markets such as Pakistan and Egypt are increasingly becoming significant players, with 452 and 1144 trials respectively. These nations are leveraging their large populations and diverse genetic pools to attract international research projects. However, challenges such as regulatory hurdles and limited funding remain significant barriers.
On the other end of the spectrum, countries like Barbados, Bolivia, and Botswana report only 1 clinical trial each, highlighting significant gaps in research capabilities. These countries face challenges such as insufficient infrastructure, lack of skilled personnel, and limited access to international funding, which hinder their potential to participate in global clinical research efforts.
Year-over-Year Trends: Movers and Shakers
Examining year-over-year changes, Turkey and Italy have shown notable increases in clinical trials, with Turkey adding 135 trials (a 7.0% increase) and Italy 18 trials (a 3.3% increase). These increases can be attributed to targeted government initiatives aimed at boosting research and development, as well as increased collaborations with international pharmaceutical companies.
In contrast, the United States experienced a decrease of 490 trials, a significant 7.3% decline. Similarly, France and the United Kingdom saw reductions of 317 and 157 trials respectively. These declines may be linked to shifts in research focus, regulatory changes, or economic factors affecting funding and resource allocation.
Implications for Global Health Innovation
The distribution of clinical trials globally has profound implications for health innovation. Countries leading in clinical trials, such as the United States, China, and Turkey, are well-positioned to advance medical research and bring innovative therapies to market. The concentration of trials in these nations suggests a competitive advantage in developing cutting-edge treatments, which can influence global health outcomes.
For countries with fewer trials, the challenge lies in building capacity and infrastructure to attract more research projects. International collaborations, policy reforms, and investment in education and training are essential strategies for these nations to enhance their participation in the global clinical research ecosystem.
Overall, the Number of Clinical Trials in 2024 reflects a complex interplay of economic, policy, and infrastructural factors that shape the global landscape of medical research and innovation.
Frequently Asked Questions About Number of Clinical Trials in 2024
Which country has the highest number of clinical trials in 2024?
The United States has the highest number of clinical trials in 2024, with 6,222 trials.
What is the average number of clinical trials per country in 2024?
The average number of clinical trials per country in 2024 is 130.
Which country has the lowest number of clinical trials in 2024?
Barbados has the lowest number of clinical trials in 2024, with only 1 trial.
What is the median number of clinical trials per country in 2024?
The median number of clinical trials per country in 2024 is 8.
How many countries are included in the dataset for clinical trials in 2024?
The dataset includes 149 countries for clinical trials in 2024.
What are the top three countries in terms of the number of clinical trials in 2024?
The top three countries in terms of the number of clinical trials in 2024 are the United States with 6,222 trials, Turkey with 2,075 trials, and China with 1,649 trials.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2024. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2024
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.